Wai Yuen Tong Medicine Holdings Ltd
HKEX:897
Wai Yuen Tong Medicine Holdings Ltd
Revenue
Wai Yuen Tong Medicine Holdings Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
W
|
Wai Yuen Tong Medicine Holdings Ltd
HKEX:897
|
Revenue
HK$1.4B
|
CAGR 3-Years
17%
|
CAGR 5-Years
11%
|
CAGR 10-Years
5%
|
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
Revenue
¥13.7B
|
CAGR 3-Years
16%
|
CAGR 5-Years
13%
|
CAGR 10-Years
9%
|
S
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Revenue
¥26.2B
|
CAGR 3-Years
3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
13%
|
C
|
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
|
Revenue
¥18.1B
|
CAGR 3-Years
7%
|
CAGR 5-Years
10%
|
CAGR 10-Years
29%
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Revenue
HK$244.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
HUTCHMED (China) Ltd
LSE:HCM
|
Revenue
$838m
|
CAGR 3-Years
54%
|
CAGR 5-Years
31%
|
CAGR 10-Years
34%
|
See Also
What is Wai Yuen Tong Medicine Holdings Ltd's Revenue?
Revenue
1.4B
HKD
Based on the financial report for Sep 30, 2023, Wai Yuen Tong Medicine Holdings Ltd's Revenue amounts to 1.4B HKD.
What is Wai Yuen Tong Medicine Holdings Ltd's Revenue growth rate?
Revenue CAGR 10Y
5%
Over the last year, the Revenue growth was 1%. The average annual Revenue growth rates for Wai Yuen Tong Medicine Holdings Ltd have been 17% over the past three years , 11% over the past five years , and 5% over the past ten years .